Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-15-000002

CEO bought 10,000 shares at an average $1.53 ($15,298)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Babcock Dwight William CEO 2015-06-09 Purchase +9,600 $1.53 $14,688 301,002 D: show line 1 in the form
Babcock Dwight William CEO 2015-06-09 Purchase +100 $1.53 $153 301,102 D: show line 2 in the form
Babcock Dwight William CEO 2015-06-09 Purchase +300 $1.53 $458 301,402 D: show line 3 in the form
Open-market purchases · 10,000 sh · avg $1.53 · $15,298
Loading xslF345X03/primary_doc.xml…